These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 4808176)
1. Antagonist Inmate Work-Release Program behavioral research design. Capone T; Brahen LS; Wiechert V Proc Natl Conf Methadone Treat; 1973; 1():405-10. PubMed ID: 4808176 [No Abstract] [Full Text] [Related]
2. A new antagonist treatment program for narcotic addicts (the first Antagonist-Inmate Work Release Program). Brahen LS; Capone T; Wiechert V Proc Natl Conf Methadone Treat; 1973; 1():401-4. PubMed ID: 4808175 [No Abstract] [Full Text] [Related]
3. Development of a nursing regime for an Antagonist Inmate Work Release Program. Wiechert V; Brahen LS; Capone T Proc Natl Conf Methadone Treat; 1973; 1():411-6. PubMed ID: 4808177 [No Abstract] [Full Text] [Related]
4. Cyclazocine treatment for heroin addicts. Kissin B; Ottomanelli G; Sang E; Halloran G Proc Natl Conf Methadone Treat; 1973; 1():658-66. PubMed ID: 4808217 [No Abstract] [Full Text] [Related]
5. The use of cyclazocine in treating narcotic addicts in a low-intervention setting. Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735 [No Abstract] [Full Text] [Related]
6. Narcotic antagonists: a reasonable method of treating narcotic dependency. Schooff KG; Hersch RG; Keegan JF Int J Addict; 1975; 10(3):391-400. PubMed ID: 170227 [TBL] [Abstract][Full Text] [Related]
10. A controlled study using cyclazocine in the treatment of narcotic addiction. Chappel JN; Jaffe JH; Senay EC Am J Drug Alcohol Abuse; 1974; 1(2):233-42. PubMed ID: 4619540 [No Abstract] [Full Text] [Related]
11. Antagonist study in St. Louis. Parwatikar S; Crawford J; Unverdi C Am J Drug Alcohol Abuse; 1975; 2(3-4):379-90. PubMed ID: 1227299 [No Abstract] [Full Text] [Related]
12. Non-addictive drug antagonist program in a community setting. LeCompte G; Friedman JJ; Sinacore R Am J Public Health; 1973 Sep; 63(9):804-6. PubMed ID: 4723737 [No Abstract] [Full Text] [Related]
13. The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism. McMillan GP; Lapham S; Lackey M Addiction; 2008 Dec; 103(12):2017-23. PubMed ID: 19469745 [TBL] [Abstract][Full Text] [Related]
14. Evolution of the National Academy of Sciences study of naltrexone. Kaim SC NIDA Res Monogr; 1976 Sep; (9):37-44. PubMed ID: 794719 [No Abstract] [Full Text] [Related]
16. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico. Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415 [TBL] [Abstract][Full Text] [Related]
17. The Key Extended Entry Program (KEEP): from the community side of the bridge. Fallon BM Mt Sinai J Med; 2001 Jan; 68(1):21-7. PubMed ID: 11135502 [TBL] [Abstract][Full Text] [Related]
19. A randomized control trial of group counseling in a naltrexone treatment program. Tucker T; Ritter A; Maher C; Jackson H J Subst Abuse Treat; 2004 Dec; 27(4):277-88. PubMed ID: 15610829 [TBL] [Abstract][Full Text] [Related]